EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Advances in Molecular Research and Treatment for Melanoma in Asian Populations

Soichiro Kado iD, Mayumi Komine iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26115370 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Soichiro Kado und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke 329-0498, Tochigi, Japan. Hauptthemen laut MEDLINE: Melanoma. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 180 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanoma treatment comprised a few treatment choices with insufficient efficacy before the emergence of molecularly targeted medication and immune checkpoint inhibitors, which dramatically improved patient outcomes. B-Rapidly Accelerated Fibrosarcoma (BRAF) and Mitogen-Activated Protein Kinase (MAPK) Kinase (MEK) inhibitors significantly improved survival in BRAF-mutant melanoma and immune checkpoint inhibitors, such as anti-programmed cell death 1 (PD-1) and Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4) agents, established new standards of care. Challenges remain, however, including the existence of resistance mechanisms and the reduced efficacy of immune-based therapies in Asian populations, particularly for acral and mucosal subtypes. This review highlights historical and current therapeutic advancements, discusses regional considerations, and explores emerging strategies aiming at globally optimizing melanoma management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaHumansAsian PeopleProto-Oncogene Proteins B-rafImmune Checkpoint InhibitorsMolecular Targeted TherapyProtein Kinase InhibitorsImmunotherapy

Stichwörter der Autor:innen

BRAF-MEK inhibitorsacral and mucosal melanomaimmune checkpoint inhibitorsmelanomatherapeutic resistance

Substanzen

Proto-Oncogene Proteins B-rafImmune Checkpoint InhibitorsProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Dermatology, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke 329-0498, Tochigi, Japan.
  • Department of Biochemistry, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke 329-0498, Tochigi, Japan.

ORCID-Profile: Soichiro Kado, Mayumi Komine

Zitieren

APA

Kado, S., & Komine, M. (2025). Recent Advances in Molecular Research and Treatment for Melanoma in Asian Populations. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26115370

Vancouver

Kado S, Komine M. Recent Advances in Molecular Research and Treatment for Melanoma in Asian Populations. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26115370

BibTeX
@article{Kado2025,
  author = {Kado, Soichiro and Komine, Mayumi},
  title = {Recent Advances in Molecular Research and Treatment for Melanoma in Asian Populations},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26115370}
}
Kostenlos starten →